Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Creech Timothy J
Relationship:   See Remarks
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   19,462    

Indirect Shares

  2,493      
Direct Value   $0    

Indirect Value

  $0      
Total Shares   21,955      
Total Value   $0      


Synageva BioPharma Corp
 $0 Synageva BioPharma Corp
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA Vice President of Fina... 2004-06-22 19,462 2004-06-22 2,493    Premium*  
            Salix Pharmaceuticals Ltd SLXP See Remarks 2015-04-01 0 0    Premium*  
* Premium Members only  

Records found :    11         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SLXP Salix Pharmaceuticals Ltd See Remarks   •       –      –    2015-04-01 4 D $173.00 $3,697,356 D/D (21,372) 0 0 -
SLXP Salix Pharmaceuticals Ltd See Remarks   •       –      –    2015-04-01 4 D $173.00 $703,245 D/D (4,065) 0 0 -
SLXP Salix Pharmaceuticals Ltd See Remarks   •       –      –    2015-03-06 4 S $157.67 $725,269 D/D (4,600) 25,437 0 -
SLXP Salix Pharmaceuticals Ltd See Remarks   •       –      –    2015-01-02 4 D $114.94 $373,325 D/D (3,248) 30,537 0 -
GEVA Synageva BioPharma Corp officerTitle   •       –      –    2003-07-24 4 S $47.00 $140,483 D/D (2,989) 12,662 -
GEVA Synageva BioPharma Corp Vice President of Finance   •       –      –    2003-10-20 4 S $25.75 $64,375 D/D (2,500) 10,162 -
GEVA Synageva BioPharma Corp Vice President of Finance   •       –      –    2003-10-20 4 OE $8.00 $20,000 D/D 2,500 12,462 -
GEVA Synageva BioPharma Corp Vice President of Finance   •       –      –    2003-10-20 4 GD $0.00 $0 D/D 200 9,962 -
GEVA Synageva BioPharma Corp Vice President of Finance   •       –      –    2004-06-22 4 A $0.00 $0 D/D 7,000 19,462 -
SLXP Salix Pharmaceuticals Ltd See Remarks   •       –      –    2015-03-06 4 GD $0.00 $0 D/D 500 30,037 0 -
SLXP Salix Pharmaceuticals Ltd See RemarksOfficer   •       –      –    2014-11-05 3 IO $0.00 $0 D/D 0 33,785 -

  11  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed